You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need

    SBC: PHOTON-X, INC.            Topic: AF192001

    Photon-X proposes to apply the Company’s patented and proven Spatial Phase Imaging (SPI) technology to numerous Focus Areas and User needs outlined in SBIR AF192-001: Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need. Our multi-patented passive optical sensors are based on Spatial Phase Imaging physics and will be a Defense- ...

    SBIR Phase I 2019 Department of DefenseAir Force
  2. Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need

    SBC: LINC RESEARCH, INC.            Topic: AF192001

    Disruptive Tuned Mass (DTM) is a passive high-performance technology providing a lightweight solution for vibration reduction and platform stabilization. DTM is a revolutionary new category of Tuned Mass System (TMS) significantly outperforming Tuned Vibration Absorbers (TVA) and Tuned Mass Dampers (TMD). DTM is a fundamentally different approach that alters the response of the structure by alteri ...

    SBIR Phase I 2019 Department of DefenseAir Force
  3. Targeting GSK3 in AML

    SBC: CuronBiotech Inc            Topic: 102

    Acute myeloid leukemiaAMLis one of the most common forms of leukemia in adults and despite advances in treatment theyear survival is less thanin adults and significantly lower in the elderlyThe remarkable success in treating one relatively uncommon subset of AMLacute promyelocytic leukemiawith all trans retinoic acidATRAillustrates the great promise for agents with greater efficacy and less toxici ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  4. SAC-COVID: An FDA-approved Phase III clinical trial evaluating the safety and therapeutic efficacy of CD24Fc in severe COVID-19 patients

    SBC: Oncoimmune Inc            Topic: 102

    Summary Although most COVID-19 patients exhibit mild to moderate clinical symptoms, a substantial portion require hospitalization with oxygen support. These patients are classified as having severe COVID-19 and have high risk of progression to an intensive care unit (ICU) with requirement for invasive mechanical ventilation, extracorporeal membrane oxygenation (ECMO), and carry high risk for morta ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
  5. Micro Identification Friend or Foe (IFF)

    SBC: R CUBED ENGINEERING LLC            Topic: N142102

    Development of a small UAS compatible Micro IFF transponder including Modes 1,2,3A,C,S , Dual band ADS-B, UAT, Mode 5 and interrogator. All modes include both receive (in) and transmit (out). Size is less than 8 cu inches and weight is under 6 oz with full AIMS 17-1000 compliance, including 500 watt output with diversity. Unit is also low cost and low maintenance. Unit meets full military temperat ...

    SBIR Phase II 2019 Department of DefenseNavy
  6. Direct to Phase II Open Topic: Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need

    SBC: IMMERSIVE WISDOM INC            Topic: AF192D001

    Today’s Air Force missions are dependent on physically separated personnel and a complex flow of never ending data from a growing number of sources across multiple domains including cyber, FMV, GEOINT, sensor platforms, and more. Existing collaboration capabilities used to communicate, analyze, and act are disjointed, inefficient and unable to keep pace with operational demands making it im ...

    SBIR Phase II 2019 Department of DefenseAir Force
  7. Direct to Phase II Open Topic: Open Call for Innovative Defense-Related Dual-Purpose Technologies/Solutions with a Clear Air Force Stakeholder Need

    SBC: Gapingvoid Culture Design Group LLC            Topic: AF192D001

    AFWERX and AFGSC have entered into a MOU to run a Culture of Innovation Project throughout the entire organization for all 10 Air Force Bases over a 20 month period. The goal of this project will be to leverage and enhance the existing work within AFGSC to create innovative leaders providing safe, secure and lethal combat-ready forces for nuclear and conventional global strike today and tomorrow. ...

    SBIR Phase II 2019 Department of DefenseAir Force
  8. V-Fasctic: Game-based Fasciotomy Trainer

    SBC: SIMETRI, INC.            Topic: AF192001

    Battlefield and traumatic injuries to the extremities often require a time-sensitive fasciotomy to prevent permanent damage and amputation—in as little as six hours, permanent damage can occur. As a result, Combat Medics and Medical Sergeants must perform fasciotomies in a variety of environments, but training for this procedure is currently inadequate to meet need. SIMETRI will apply its p ...

    SBIR Phase I 2019 Department of DefenseAir Force
  9. Evaluation of therapeutic efficacy and safety of novel small RNA target delivery platform in vivo.

    SBC: Oncoimmune Inc            Topic: 100

    Project Summary AbstractThe recent rapid expansion of genomic data greatly contributes to the understanding of disease development and progressionTo translate these genetic discoveries into clinical applicationswe need to develop therapeutic platforms that can specifically modulate the expression of disease related genes in vivoSmall RNAssuch as microRNAs and siRNAs function in messenger RNA silen ...

    STTR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  10. Telemetric Microsensor for Glaucoma

    SBC: H-CUBED            Topic: NEI

    PROJECT SUMMARY Glaucoma is an optic nerve disease in which there is progressive loss of retinal ganglion cells leading to irreversible loss of vision. It is estimated to affect 2% of the general population. More than 2.3 million Americans are affected with glaucoma and it is estimated to account for nearly $3B in direct medical costs. It is estimated that 4% of Caucasian patients and 8% of Africa ...

    SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government